NCT03344003 - Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

November 20, 2020

Study Completion Date

November 20, 2020

Conditions

Hemophilia A

Interventions

DRUG

Wilate or Nuwiq

Wilate or Nuwiq administered via intravenous injection

Trial Locations (3)

Stollery children's hospital, University of Alberta, Edmonton

Children's Hospital of Eastern Ontario, Ottawa

Hamilton Health Science center, Toronto